| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 20 |
| 1 | SORAFENIB | 15 |
| 2 | ADALIMUMAB | 13 |
| 3 | FUROSEMIDE | 11 |
| 4 | OMEPRAZOLE | 9 |
| 5 | OMEPRAZOLE MAGNESIUM | 9 |
| 6 | WARFARIN | 9 |
| 7 | NIFEDIPINE | 8 |
| 8 | WARFARIN SODIUM | 7 |
| 9 | ASPIRIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPHEDRINE SULFATE | 1 | 0.0046 |
| 1 | MITOTANE | 4 | 0.0022 |
| 2 | FILGRASTIM-AAFI | 1 | 0.0015 |
| 3 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 4 | ETHIODIZED OIL | 1 | 0.0008 |
| 5 | SORAFENIB | 15 | 0.0007 |
| 6 | NORETHINDRONE | 4 | 0.0007 |
| 7 | IDARUCIZUMAB | 1 | 0.0007 |
| 8 | TREMELIMUMAB | 3 | 0.0007 |
| 9 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 22 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 |
| 2 | Kinase Inhibitor [EPC] | 18 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 4 | Proton Pump Inhibitor [EPC] | 13 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 11 |
| 6 | Loop Diuretic [EPC] | 11 |
| 7 | Benzodiazepine [EPC] | 10 |
| 8 | Alkylating Drug [EPC] | 7 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 1 | Oxytocic [EPC] | 1 | 0.0003 |
| 2 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 4 | 0.0002 |
| 4 | CTLA-4-directed Blocking Antibody [EPC] | 7 | 0.0001 |
| 5 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 20 | 0.0001 |
| 6 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | Bile Acid [EPC] | 2 | 0.0001 |
| 9 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |